About Dylan Sammut
Articles Written by Dylan Sammut
Genentech Bets on Bicycle-Based Therapies
Genentech, a subsidiary of the Roche Group (OTCMKTS: RHHBY), is betting big on a collaboration effort with Bicycle Therapeutics plc (NASDAQ: BCYC). The exclusive collaboration agreement between the two biotechnology companies hopes to develop and commercialize... Read More »
eHealth M&A Still Strong Despite Slow February
Despite a slow February, eHealth M&A activity remained busy throughout the month. There were 16 deals publicly announced transactions, according to our Deal Search Online database, a slight drop from the 19 disclosed in January. That’s roughly 23% of all... Read More »
Health Care M&A Deals, February 28, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most... Read More »Citadel Group Goes International
The Citadel Group Limited (ASX: CGL), an Australia-based business services company, announced this month it was acquiring Wellbeing Software for roughly $134 million, or 6.2x the group’s 2019 revenue of $21.6 million. Elysian Capital is selling the eHealth firm,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
